Pro Share Advisors LLC Gilead Sciences, Inc. Transaction History

Pro Share Advisors LLC

$36.7 Billion
Q1 2024

A detailed history of Pro Share Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 1,480,987 shares of GILD stock, worth $102 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

1,480,987

Previous 1,217,342 21.66%

Holding current value

$102 Million

Previous $98.6 Million 10.0%

% of portfolio

0.3%

Previous 0.31%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$71.58 - $87.29 $18.9 Million - $23 Million	263,645 Added 21.66%	1,480,987 $108 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $15.7 Million - $17.8 Million	-213,934 Reduced 14.95%	1,217,342 $98.6 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $12.2 Million - $13.3 Million	165,000 Added 13.03%	1,431,276 $107 Million
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $4.94 Million - $5.64 Million	-64,995 Reduced 4.88%	1,266,276 $97.6 Million
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $8.61 Million - $9.81 Million	111,328 Added 9.13%	1,331,271 $110 Million

Q4 2022 Feb 02, 2023	SELL	$62.32 - $89.47 $10 Million - $14.4 Million	-160,923 Reduced 11.65%	1,219,943 $105 Million
Q3 2022 Nov 04, 2022	SELL	$59.54 - $68.01 $14.9 Million - $17.1 Million	-250,845 Reduced 15.37%	1,380,866 $85.2 Million
Q2 2022 Aug 01, 2022	SELL	$57.72 - $65.01 $46 Million - $51.8 Million	-796,722 Reduced 32.81%	1,631,711 $101 Million
Q1 2022 May 10, 2022	SELL	$57.92 - $72.58 $7.34 Million - $9.19 Million	-126,666 Reduced 4.96%	2,428,433 $144 Million
Q4 2021 Feb 08, 2022	BUY	$64.88 - $73.64 $49.9 Million - $56.6 Million	768,758 Added 43.04%	2,555,099 $186 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $11.5 Million - $12.4 Million	169,819 Added 10.51%	1,786,341 $125 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $1.27 Million - $1.39 Million	-20,008 Reduced 1.22%	1,616,522 $111 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $13.3 Million - $15.1 Million	220,876 Added 15.6%	1,636,530 $106 Million
Q4 2020 Feb 09, 2021	BUY	$56.65 - $64.55 $10.9 Million - $12.4 Million	191,724 Added 15.66%	1,415,654 $82.5 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $11.9 Million - $14.9 Million	191,280 Added 18.52%	1,223,930 $77.3 Million
Q2 2020 Aug 03, 2020	BUY	$72.34 - $84.0 $9.94 Million - $11.5 Million	137,440 Added 15.35%	1,032,650 $79.5 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $23.7 Million - $30.4 Million	-379,066 Reduced 29.75%	895,210 $66.9 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $6.98 Million - $7.68 Million	113,236 Added 9.75%	1,274,276 $82.8 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $1.32 Million - $1.46 Million	21,133 Added 1.85%	1,161,040 $73.6 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $10.2 Million - $11.4 Million	-164,587 Reduced 12.62%	1,139,907 $77 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $2.14 Million - $2.4 Million	34,274 Added 2.7%	1,304,494 $84.8 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $9.34 Million - $12.2 Million	154,322 Added 13.83%	1,270,220 $79.5 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $8.39 Million - $9.29 Million	-117,774 Reduced 9.55%	1,115,898 $86.2 Million
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $5.31 Million - $6.19 Million	-81,803 Reduced 6.22%	1,233,672 $87.4 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $6.74 Million - $8.22 Million	92,535 Added 7.57%	1,315,475 $99.2 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $18.3 Million - $21.5 Million	256,850 Added 26.59%	1,222,940 $87.6 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $2.13 Million - $2.53 Million	29,577 Added 3.16%	966,090 $78.3 Million
Q2 2017 Aug 11, 2017	BUY	N/A	936,513	936,513 $66.3 Million

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Gilead Sciences, Inc. Transaction History